Welcome to the website and services provided by NCV Media, LLC,
(“New Cannabis Ventures”), which can be found at www.newcannabisventures.com, (the “Site”).

New Cannabis Ventures connects the cannabis industry through curated content on only the most promising cannabis companies and the most influential investors, allowing its visitors to save time as they stay on top of the latest trends in this dynamic industry. Curated content that gets published ranges from company specific to industry wide news, as well as information, opinion, analysis and commentary.

The Site and any information therein are provided without warranty of any kind, including the implied warranties of merchantability, fitness for use of a particular purpose, accuracy, or non-infringement. New Cannabis Ventures does not guarantee that the Site will operate in an uninterrupted or error-free manner or is free of viruses or other harmful components. Use of information obtained from or through the Site is at your own risk. The Site is not liable for any loss or damages including, but not limited to, claims for defamation, errors, loss of data, loss of money, or interruption in availability of data arising out of the use or inability to use the Site or any links; to your placement of content on the Site; or to your reliance upon information obtained from or through the Site or through links contained on the Site.

This Site is not an intermediary, broker/dealer, investment advisor, or exchange and does not provide investment advice or investment advisory services. New Cannabis Ventures does not condone the use of cannabis except where permissible by state law. The Site does not possess, distribute, or sell cannabis products.

Commerce Policy
New Cannabis Ventures receives affiliate payments through various partners which includes the Cannabis Capital Conference, by Benzinga and the newsletter subscription service, 420 Investor.

Responsible awareness and public disclosure
New Cannabis Ventures is proud to offer fact-based, data-driven “Investor Dashboards” for publicly-traded advertising clients. The information displayed on each Investor Dashboard is often based on regulatory filings from SEC, SEDAR or a common regularly authority, official company press releases or publicly available company brochures. Advertising the Investor Dashboards, maintaining its data and the complimentary ad banners that come with it is the solution New Cannabis Ventures provides. Clients cannot buy the ability to publish favorable articles on the platform. The goal of the Investor Dashboard is to ensure the reader has the most up to date and factual information that is publicly available. All data and info is provided “as is” and solely for informational purposes, not for trading or investment advice. New Cannabis Ventures does not accept any form of compensation from publicly-traded companies unless they are disclosed below. Pricing for the Investor Dashboard product is made available on the New Cannabis Ventures advertising page.

Ethics Policy
NCV Media provides or has provided Investor Dashboards to the following publicly-traded companies:

48North – 01/07/19-1/7/20, Aurora Cannabis – 10/1/16-09/30/20, Australis Capital – 10/30/18-04/29/19, AYR Wellness – 11/06/20-05/08/23, Body and Mind – 10/31/20-8/31/22, Canopy Growth Corporation – 10/1/16-03/31/20, Canopy Rivers – 09/18/18-02/04/19, CB2 Insights – 03/06/19 (as a public company)-6/14/19, Charlotte’s Web – Start date: 09/06/18-06/05/22, Cresco Labs – 12/03/18-12/08/22, DionyMed Brands – 07/01/19-12/6/19, Emblem Corp. – 12/12/16 (as a public company)-02/28/19 (following agreement to merge with Aleafia Health), Emerald Health – 01/16/17-03/31/17, Fire and Flower – Start date: 06/26/19-06/25/2022, GABY Inc – 8/14/19-11/13/19, Greenlane – 09/01/21-08/31/23, Green Growth Brands – 11/13/18-11/24/19, Goodness Growth Holdings (formerly Vireo) -04/30/19-11/30/21 04/30/19, GrowGeneration – 01/01/17-03/31/18, Harborside – Start date: 09/21/20-03/27/22, Harvest One Cannabis – 04/01/17-12/31/19, High Tide – 02/01/19-05/09/19, Hiku Brands (formerly DOJA Cannabis) – 7/25/17-7/31/18 (following agreement to merge with Canopy Growth), Humble & Fume -Start date: 11/15/21-05/15/22. iAnthus Capital Holdings – 04/20/17-04/30/20, IM Cannabis – Start date: 07/09/21-04/08/22, INDIVA –  07/24/18-10/24/20 and then from 07/09/21-01/08/22, Jushi Holdings – Start date: 08/26/20-08/25/22, Khiron Life Sciences – 05/23/18-08/22/18, KushCo Holdings (Kush Bottles) – 02/15/17-08/31/21, Liberty Health Sciences – 08/01/17-12/31/19, Lowell Farms – 10/27/20-12/09/22, Medicine Man Technologies – 09/25/18-01/24/21, MediPharm Labs – 10/01/18-04/14/20, MJardin Group – 11/15/18-05/31/19 (as a public company), MPX Bioceutical Corporation (formerly The Canadian Bioceutical Corporation) – 06/15/17-01/31-19 (following acquisition by iAnthus Capital), MPX International –  05/30/19-02/29/20, OrganiGram – 01/01/17-03/31/17 and 09/12/18-9/11/20, Plus Products – 10/29/18 (as public company)-9/30/21, RavenQuest BioMed – 11/28/17-08/31/18, Rubicon Organics  – 02/13/21-08/12/21, Solis Tek –  04/16/17-10/31/17, Supreme Cannabis – 04/14/17-02/15/20, TerrAscend –  09/20/17-03/28/22, The Green Organic Dutchman -11/25/16-10/10/18, The Parent Company –  02/26/21-02/25/22, Therapix Biosciences –  03/22/17-07/26/17, TILT Holdings – 06/20/19-02/20/20 and 7/28/21-03/28/23, Trichome Financial – 11/29/20-03/31/21, urban-gro – Start date: 02/11/21, Valens Company – 03/10/21-03/09/22, Vivo Cannabis (Formerly ABcann) – 04/24/17 -12/31/19 (as a public company), Wayland Group Corp (formerly Maricann) – 04/22/17-04/30/19. We also provided the following companies with advertising services by including them on our Cannabis Careers page: Organigram – 05/30/18-08/29/18.

Publicly-traded client criteria
Please note as well, being a client of New Cannabis Ventures is not a recommendation of the company. In determining which public companies are eligible to be a client of New Cannabis Ventures, they must meet a minimum standard. Meeting these criteria is not a guarantee that New Cannabis Ventures will accept a company as a client. Note that there are slightly different standards for companies who have a license issued by federal or state governments. The criteria can be found at the bottom of this page.

Ancillary Company Criteria

  • $1 minimum stock price for annual sales <$5mm
  • $0.10 minimum stock price for annual sales >$5mm
  • No history of stock promotion
  • No toxic debt
  • Current in filings

Licensed Company Criteria

  • A license issued by federal or state government
  • A demonstrated capacity to raise capital
  • No history of stock promotion
  • No toxic debt
  • Current in filings